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Abstract 
The expression of various components of the lysosomal and ubiquitin-dependent degradative pathways was characterized in an in vitro 
model of differentiating ente.rocytes, the human colon adenocarcinoma C co-2 cell line. The activities of the cell-associated lysosomal 
enzymes a-D-mannosidase, fl-hexosaminidase, fl-glucuronidase, and fl-galactosidase increased ~ 2- to 4-fold as differentiation 
proceeded. In contrast, he protein levels of the two mannose 6-phosphate r ceptors (MPRs), the insulin-like growth factor II/cation-inde- 
pendent MPR (IGF-II/CI-MPR) and the cation-dependent MPR (CD-MPR), did not change significantly during Caco-2 differentiation. In
addition, quantitative Western blot analyses revealed that on a molar basis the CD-MPR is 3.5 times more abundant han the 
IGF-II/CI-MPR in Caco-2 cells. Since only limited secretion of lysosomal enzymes was observed throughout differentiation, the level of 
expression of the MPRs wa:~ sufficient o target he increased levels of lysosomal enzymes to the lysosome. Unlike the expression of 
lysosomal enzymes, Western blot analysis demonstrated an ~ 40% and ~ 30% decrease, respectively, in the steady-state levels of free 
and conjugated ubiquitin during Caco-2 differentiation. Taken together, these results show that the ubiquitin-dependent proteolytic 
pathway is regulated ifferently than the lysosomal degradative pathway during Caco-2 differentiation. 
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1. Introduction 
Several distinct pathways for the intracellular degrada- 
tion of proteins are known to exist in eukaryotic ells. The 
lysosomal pathway functions in the degradation of numer- 
ous long-lived cytosolic proteins, endocytosed proteins, 
and endogenous organelles [1]. Key components of this 
degradative pathway are mannose 6-phosphate receptors 
(MPRs) that participate in the delivery of newly synthe- 
sized lysosomal enzymes bearing the mannose 6-phosphate 
(Man-6-P) recognition marker to the lysosome. Two dis- 
tinct but homologous MPRs have been identified (for 
reviews see Refs. [2-4]). The insulin-like growth factor 
II/cation-independent M?R (IGF-II/CI-MPR) is a 275 
kDa membrane glycoprotein which binds both Man-6-P on 
lysosomal enzymes and IGF-II, a non-glycosylated 
Abbreviations: Man-6-P, mamnose 6-phosphate; MPR, mannose 6- 
phosphate r ceptor; IGF-II. insulin-like growth factor II; IGF-II/CI-MPR, 
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polypeptide hormone [5,6]. The 46 kDa cation-dependent 
MPR (CD-MPR) is also a membrane glycoprotein but, 
unlike the IGF-II/CI-MPR, it does not bind IGF-II [5,7]. 
The ubiquitin pathway is involved in the breakdown of 
short-lived and abnormal proteins [8,9] and has been pro- 
posed to play a regulatory role in DNA repair, cell cycle 
control, and cellular differentiation (for reviews see Refs. 
[10,11]). Ubiquitin is a highly conserved 76-amino acid 
cytosolic protein which can be ligated post-translationally 
to a variety of cytosolic and membrane proteins by an 
ATP-dependent process, resulting in the formation of an 
isopeptide bond between ubiquitin and substrate proteins. 
For many proteins, the addition of ubiquitin serves as a 
marker to target protein substrates for degradation by a 
multicomponent complex, the 26S protease [12]. 
The adult intestinal epithelium undergoes continuous 
cell renewal involving rapid proliferation and differentia- 
tion processes [13]. To begin to address the roles of the 
various degradative pathways in cellular differentiation 
events of enterocytes, the levels of lysosomal enzymes, 
MPRs, ubiquitin, and ubiquitin-protein conjugates were 
characterized in the human colon adenocarcinoma C co-2 
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cell line. Under normal culture conditions, Caco-2 cells 
differentiate spontaneously after reaching confluence and 
acquire numerous characteristics of enterocytes, including 
a polarized morphology with brush-border membranes, 
tight junction formation, transepithelial transport of macro- 
molecules, and the expression of brush-border enzymes 
that are differentiation-specific markers for small intestinal 
enterocytes [14-18]. Our results demonstrate hat the activ- 
ity of several ysosomal enzymes increases during Caco-2 
differentiation while the level of the MPRs remains con- 
stant. In comparison to proliferative cells, post-confluent 
differentiated Caco-2 cells exhibit an ~ 30% decrease in 
the steady-state level of ubiquitin-protein conjugates. Thus, 
both the lysosomal and ubiquitin degradative pathways are 
regulated in a differentiation-dependent fashion in Caco-2 
cells. 
2. Materials and methods 
2.1. Materials 
The following reagents were obtained commercially as 
indicated: EN3HANCE, EXPRE35S35S [35S]protein label- 
ing mix (1200 Ci/mmol) which contains ~ 70% 
[3SS]methionine and ~ 20% [35S]cysteine, and c~-[ 32 P]UTP 
(800 Ci/mmol) (DuPont-New England Nuclear), Na125I, 
carrier-free (Amersham), Immobilon-P transfer membrane 
(Millipore), BioRad protein assay (BioRad), ribonuclease 
A (Sigma), T3 and T7 RNA polymerase (Molecular Biol- 
ogy Resource), ribonuclease T 1 (Ambion), AMV reverse 
transcriptase and Taq DNA polymerase (Promega), syn- 
thetic oligonucleotides (Operon Technologies), peptide:N- 
glycosidase F (PNGase F) (Boehringer Mannheim), Dul- 
becco's modified Eagle's medium (DMEM) and trypsin- 
EDTA (Gibco-BRL Life Technologies), fetal bovine serum 
(HyClone Laboratories). Caco-2 cells [14] were kindly 
provided by Dr. Ward Olsen of Veterans Administration 
Hospital (Madison, WI). Phosphomannan from Hansenula 
holstii was a gift of Dr. M.E. Slodki of the Northern 
Regional Research Center (Peoria, IL). 
2.2. Cell culture 
Caco-2 cells (passages 76-120) were grown in DMEM 
(25 mM glucose) supplemented with 20% heat-inactivated 
fetal bovine serum, 4 mM glutamine, 100 U/ml  penicillin, 
and 100 /zg/ml streptomycin a humidified atmosphere 
containing 5% CO 2. Confluent monolayers were subcul- 
tured every 7 days by treatment with 0.05% trypsin and 
0.53 mM EDTA in phosphate-buffered saline. For differ- 
entiation studies, Caco-2 cells were seeded at a density of 
2.7. 10 4 cells/cm 2 and reached confluence 6 days after 
plating. In some experiments, the cells were labeled in 
methionine-free DMEM containing 10% heat-inactivated 
fetal bovine serum and EXPRE35S35S [35S]protein labeling 
mix (100 #Ci/ml)  for 16-20 h. 
2.3. Lysosomal enzyme assays 
Caco-2 cells were washed with buffer containing 10 
mM Tris (pH 7.4) and 140 mM NaCI (TBS buffer), and 
homogenized by sonication in TBS buffer containing Tri- 
ton X-100 (1%, v/v), aprotinin (1%, v/v), antipain (4 
/xg/ml), benzamidine (20 /xg/ml), and 2 /xg/ml each of 
leupeptin, chymostatin, and pepstatin. Aliquots of the ex- 
tract were then assayed for the following lysosomal en- 
zyme activities: a-D-mannosidase was measured using p- 
nitrophenyl-a-D-mannopyranoside as the substrate [19], 
/3-galactosidase was measured using p-nitrophenyl-/3-D- 
galactopyranoside as the substrate [20], /3-glucuronidase 
was measured using p-nitrophenyl-/3-D-glucuronide as the 
substrate [21], and /3-hexosaminidase was measured as 
described for /3-glucuronidase [21] except that p- 
nitrophenyl-N-acetyl-/3-D-glucosaminide was used as the 
substrate. One unit of enzyme is defined as the amount of 
enzyme that releases 1 /xmol of p-nitrophenol in 1 min at 
37°C. 
2.4. Pentamannosyl phosphate-agarose affinity chromatog- 
raphy 
To purify the MPRs, the cells were solubilized with 1% 
Triton X-100 and subjected to pentamannosyl phosphate- 
agarose affinity chromatography as described previously 
[22]. The columns were eluted in buffer containing 5 mM 
glucose 6-phosphate (non-specific ligand) followed by 5 
mM Man-6-P (specific ligand). The glucose 6-phosphate 
and Man-6-P eluates were precipitated with 10% trichloro- 
acetic acid and subjected to gel electrophoresis under 
reducing conditions using the buffer systems of Laemmli 
[23]. Radiolabeled MPRs were visualized by fluorography 
of gels impregnated with EN3HANCE. In some experi- 
ments, an aliquot of the Man-6-P eluate was digested with 
PNGase F prior to SDS-PAGE [24]. 
2.5. Isolation of a partial cDNA clone for human CD-MPR 
and human IGF-H / CI-MPR 
A cDNA clone encompassing nucleotides 125-479 of 
the human CD-MPR [25] was obtained by polymerase 
chain amplification of cDNA that was reverse transcribed 
from human liver total RNA [26]. The reverse transcriptase 
reaction was carried out for 1 h at 42 ° C in a mix consist- 
ing of 2.5 /xg human liver total RNA, 1 mM dNTPs, 13 U 
RNasin inhibitor, and 1 U AMV reverse transcriptase. An 
oligonucleotide (0.3 /~g) corresponding to nucleotides 
462-479 of the non-coding strand of human CD-MPR (5' 
TCC TCA GAC ACA GGG TTA 3') was used as the 
primer. The resulting cDNA was then amplified in a 
polymerase chain reaction (PCR) utilizing the above oligo- 
nucleotide and an oligonucleotide corresponding to nu- 
cleotides 125-142 of the coding strand of human CD-MPR 
(5' CAG AGA AAG AGT TGG CTC 3'). The PCR 
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product (355 bp) was subcloned into the EcoRV site of the 
multiple cloning region of the plasmid pBluescript KS 
(Stratagene) and subjected to double-stranded DNA se- 
quence analysis to confirm the predicted sequence [27]. A 
cDNA clone encompassing nucleotides 7072-7611 of the 
human IGF-II/CI-MPR [28] was generated as described 
above except that the following oligonucleotides were 
used: (5' GTG CTC AGC CTG CTG CTG GT 3') encodes 
the coding strand of tl~e human IGF-II/CI-MPR from 
nucleotides 7072 to 7091 and (5' GAG GTC CTC GTC 
GCT GTC GT 3') encodes the non-coding strand of the 
human IGF-II/CI-MPR from nucleotides 7592 to 7611. 
The PCR product (540 bp) was digested with PvulI and 
HindlII to generate a 197 bp fragment corresponding to
nucleotides 7076-7272 of the human IGF-II/CI-MPR 
which was subsequently subcloned into pBluescript KS 
and subjected to double-stranded DNA sequence analysis 
to confirm the predicted sequence [27]. 
2.6. Solution-hybridization ribonuclease (RNase) protec- 
tion assay 
Total RNA was isolated from Caco-2 cells by the 
guanidinium thiocyanate method [29]. The amount of RNA 
obtained was estimated by absorbance r adings at 260 nm. 
The RNase protection assay was carried out essentially as 
described by Krieg and Melton [30]. Bluescript plasmids 
containing either the partial human CD-MPR (355 bp) or 
IGF-II/CI-MPR (197 bp) cDNA were linearized with 
EcoRI or XhoI, respectively, and the radiolabeled anti- 
sense probes were synthesized by in vitro transcription 
using bacteriophage T3 or T7 RNA polymerase in the 
presence of a-[ 32 P]UTP. Following purification on a dena- 
turing 8 M urea/5% acrylamide gel, the full-length ra- 
dioactive probe was hybridized with ~ 10 /xg of Caco-2 
total RNA at 42-44 °C for 16-20 h. Excess single-stranded 
probe was digested by RNase A and T~ for 30 min at 
37 ° C. Subsequently, the fraction of the probe that was 
protected by forming double strands with CD-MPR or 
IGF-II/CI-MPR mRNA was resolved on a denaturing 8 M 
urea/5% acrylamide ge] and visualized by autoradiog- 
raphy. The intensity of the radiolabeled bands was quanti- 
fied on an Ambis-radioimaging system and normalized to 
total RNA in the sample as determined by parallel analyses 
of rRNA in formaldehyde-agarose gelsstained with ethid- 
ium bromide. The intensity of the ethidium stained 28S 
rRNA bands was quantified on an Ambis-radioimaging 
system and was linear between 0.5-5.0 /zg of total RNA. 
2, 7. Western blot analysis of  MPRs and ubiquitin 
MPRs were purified from Caco-2 cell extracts by penta- 
mannosyl phosphate-agarose chromatography as described 
above. To ensure completeness of the purification, the 
run-through fractions were applied to a second affinity 
column. The Man-6-P eluates containing the MPRs were 
precipitated with 10% trichloroacetic a id and subjected to 
quantitative Western blot analysis as described previously 
[31]. Greater than 90% of the MPRs were isolated in the 
initial round of affinity chromatography. Purified bovine 
liver IGF-II/CI-MPR and CD-MPR (concentrations were 
determined by amino acid analysis) were used as the 
standards on the same gels as the samples. The Immo- 
bilon-P membranes were incubated with either CD-MPR- 
or IGF-II/CI-MPR-specific antisera plus [125I]protein A. 
The binding of [125I]protein A to purified MPRs is linear 
over a range of 5-275 ng [31]. To determine the levels of 
ubiquitin and ubiquitin-protein conjugates in Caco-2 cells, 
cell samples were solubilized in SDS sample buffer, re- 
solved on a 14% SDS-polyacrylamide gel, transferred 
electrophorectically to nitrocellulose, and then probed for 
the presence of free and conjugated ubiquitin by incuba- 
tion with affinity-purified rabbit polyclonal ubiquitin- 
specific antisera plus [125I]protein A as described previ- 
ously [32]. The membranes were exposed to Kodak XAR-5 
film at -70°C with Cronex Lightning Plus intensifying 
screens (DuPont-New England Nuclear) and the intensity 
of the radiolabeled bands was quantified on an Ambis-ra- 
dioimaging system. The results were then normalized to 
the total protein in the sample as determined by the 
Bradford dye binding assay (BioRad). 
3. Results 
3.1. Caco-2 differentiation 
Phase contrast microscopic examination of Caco-2 cells 
revealed that the cells reached confluence 6 days after 
plating. Analysis of the cells at various times in culture 
showed an increase in cell number which was paralleled 
by an increase in total cellular protein. However, the total 
protein and cell number each a plateau by 9 days after 
plating when Caco-2 cells have entered a stationary phase 
of growth. The protein content was 0.29 + 0.05 mg per 
10 6 cells, a value which did not change significantly 
throughout the culture period and is similar to previously 
reported values for Caco-2 cells [33]. Caco-2 cells har- 
vested at different imes after plating were assayed for 
alkaline phosphatase and sucrase activities, which are char- 
acteristic markers of the brush-border microvilli of entero- 
cytes and are indicative of differentiated Caco-2 cells [14]. 
Alkaline phosphatase and sucrase activities increased 2.5- 
fold and 206-fold, respectively, after 15 days of growth 
when compared to Caco-2 cells grown for 3 days in 
culture. These results are typical of the values reported for 
the induction of these enzymes during Caco-2 differentia- 
tion [14]. These results demonstrate that post-confluent 
Caco-2 cells acquire characteristics of mature enterocytes, 
thus confirming the ability of Caco-2 cells to undergo 
spontaneous differentiation i  culture as previously re- 
ported [14]. 
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3.2. Activity of lysosomal enzymes during Caco-2 differen- 
tiation 
To determine whether the expression of lysosomal en- 
zymes is regulated uring Caco-2 differentiation, the activ- 
ities of four different lysosomal enzymes, /3-hexosamini- 
dase (Fig. 1A), /3-glucuronidase (Fig. 1B), a-D-mannosi- 
dase (Fig. 1C), and fl-galactosidase (Fig. ID), were mea- 
sured in Caco-2 cell extracts. The results show that the 
activity of each of the four lysosomal enzymes increased 
2- to 4-fold as Caco-2 differentiation progressed. Very low 
activities of these lysosomal enzymes were detected in the 
medium (data not shown). These results demonstrate hat 
proliferative Caco-2 cells contain significantly lower levels 
of lysosomal enzymes than differentiated Caco-2 cells, and 
that the secretion of lysosomal enzymes is minimal in both 
proliferative and differentiated cells. 
3.3. Synthesis of MPRs during Caco-2 differentiation 
To examine the expression of the IGF-II/CI-MPR and 
CD-MPR,  Caco-2 cells were labeled with 
[35S]methionine/cysteine o  the indicated days and the 
MPRs were isolated from cell lysates by pentamannosyl 
phosphate-agarose affinity chromatography. On each of the 
days analyzed, two bands with apparent M r of ~ 300 kDa 
and ~ 43 kDa, corresponding to the IGF-II/CI-MPR and 
CD-MPR [2], respectively, were eluted specifically from 
the affinity column by Man-6-P (Fig. 2A). The variability 
in intensity of the MPR bands seen between the samples is 
due to isolation of the MPRs from different numbers of 
cells (the day 3 and day 6 samples contain 6-fold and 
2-fold, respectively, fewer cells than the day 9, 12, or 15 
samples) and from the observation that day 3 and day 6 
Caco-2 cells incorporate 4- to 5-fold higher levels of 
[35S]methionine/cysteine per milligram total protein than 
post-confluent cells (Wick and Dahms, unpublished ata). 
The CD-MPR synthesized by Caco-2 cells grown in cul- 
ture for 12 or 15 days exhibited a slightly faster mobility 
(M r = ,~ 41 kDa) than the CD-MPR synthesized by Caco-2 
cells grown in culture for 3 to 9 days. To determine 
whether these differences in apparent size could be due to 
changes in the glycosylation of the receptor, CD-MPRs 
isolated from Caco-2 cells after various times in culture 
were digested with PNGase F to remove N-linked oligo- 
saccharides. The resulting deglycosylated receptors were 
then analyzed by SDS-PAGE (Fig. 2B). The results show 
that treatment with PNGase F completely abolished the 
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Fig. 1. Expression of lysosomal enzymes during Caco-2 differentiation. Caco-2 cells were harvested on the days indicated and assayed for 
/3-hexosaminidase (a), fl-glucuronidase (b), a-D-mannosidase (c), and fl-galactosidase (d) activities using the corresponding p-nitrophenol substrates as 
described in Section 2. The values represent the mean of duplicate measurements that have been normalized to total cellular protein, and are representative 
of three independent collections. 
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Fig. 2. Biosynthesis of MPRs during Caco-2 differentiation. (A) One 
60-mm dish of Caco-2 cells was labeled with [35S]methionine/cysteine 
on each of the indicated days. I~le MPRs were purified by passage ofthe 
Caco-2 cell lysates over pentamannosyl phosphate-agarose c lumns which 
were eluted first with glucose 6-phosphate (non-specific l gand) and then 
Man-6-P (specific ligand). The glucose 6-phosphate (G) and Man-6-P 
(M) eluates were resolved on a 10% SDS-polyacrylamide gel. (B) 
Purified CD-MPRs were inculzated in the absence (lanes 1,3,5,7,9) or 
presence (lanes 2,4,6,8,10) of PNGase F and analyzed on a 12.5% 
SDS-polyacrylamide gel. The r~igration f the completely deglycosylated 
CD-MPR is indicated (") and corresponds to the size of the receptor 
synthesized byin vitro translation using a reticulocyte lysate system [49]. 
The migration ofmolecular weight standards is indicated. 
difference in mobility observed between the CD-MPRs 
isolated from Caco-2 celh after various days in culture. In 
contrast, digestion with Clostridium perfringens neu- 
raminidase did not significantly affect the mobility of the 
purified CD-MPRs (data not shown). These results demon- 
strate that the CD-MPR isolated from proliferative Caco-2 
cells contains different ypes of N-linked oligosaccharide 
structures than the CD-MPR isolated from differentiated 
Caco-2 cells and that these differences in glycosylation are 
not due to changes in sialylation. 
3.4. Analysis of  CD-MPI~ gene expression during Caco-2 
differentiation 
To investigate the expression levels of the MPR genes 
during Caco-2 differentiation, total RNA was isolated from 
Caco-2 cells after various times in culture. A sensitive 
RNase protection assay was performed and the integrity 
and amount of RNA used for each assay was evaluated by 
analyzing the RNA resolved on parallel formaldehyde- 
agarose gels stained with ethidium bromide. Densitometric 
scanning of the ethidium bromide stained rRNA bands 
(Fig. 3A) showed that the intensity of the 28S and 18S 
rRNA bands was linear between 0.5 and 5.0 /xg of total 
RNA (Fig. 3B and data not shown). The intensity of the 
28S rRNA band was used to determine the relative amounts 
of RNA in each sample for subsequent ormalization of 
the RNase protection data to total RNA. The results of a 
representative RNase protection assay using an antisense 
CD-MPR probe is shown in Fig. 4A. Densitometric scan- 
ning of the autoradiograph (Fig. 4A) was normalized to 
total RNA as determined by quantifying the intensity of 
28S rRNA stained with ethidium bromide in parallel gels 
(data not shown). The results are summarized in Fig. 4B 
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Fig. 3. Quantitation f total RNA by analysis of ethidium bromide stained 
28S rRNA. (A) The indicated amounts oftotal RNA were resolved on a 
1.2% formaldehyde-agarose gel, stained with ethidium bromide, and 
visualized under ultraviolet light. Each lane (1-6) contains 0.7, 1.4, 2.1, 
2.8, 3.5, and 4.2 /.tg of total RNA, respectively. The migration of 28S 
and 18S rRNA is indicated. (B) The intensity of the 28S and 18S rRNA 
ethidium bromide-stained bands was quantified using an Ambis-radio- 
imaging system. 
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Fig. 4. Expression of CD-MPR during Caco-2 differentiation. (A) Total 
RNA was isolated from Caco-2 cells on the indicated days in culture. 
RNA ( ~ 10 /xg) was hybridized in solution to a CD-MPR probe and a 
RNase protection assay was performed as described in Section 2 (lanes 
3-7). Yeast tRNA (10 /xg) was used as a negative control for any 
non-specific protection of the probe (lane 2). The size of the protected 
fragment is indicated (355 nts) as determined by migration with DNA 
sequencing ladders and corresponds to the expected full-length protection 
product. (B) The relative levels + S.E. of CD-MPR mRNA normalized to 
total RNA is shown during Caco-2 differentiation. The radiolabeled bands 
in A were normalized to the total RNA in the sample by quantifying the 
intensity of 28S rRNA stained with ethidium bromide in parallel gels 
using an Ambis-radioimaging system. CD-MPR mRNA present in day 3 
Caco-2 cells was arbitrarily set to 100% (n = 6 from 3 independent RNA 
collections; P < 0.004 for day 12 or 15 vs day 6). (C) Purified bovine 
liver CD-MPR (50-400 ng) and aliquots of CD-MPR isolated from two 
100 mM dishes of Caco-2 cells at the indicated days of culture (1.51, 
2.23, 3.00, 3.86, and 3.49 mg of total cellular protein was used for day 3, 
6, 9, 12, and 15 samples, respectively) were electrophoresed on a 10% 
polyacrylamide gel, transferred to Immobilin-P membrane, and incubated 
with a CD-MPR-specific antisera plus [n25I]protein A. The samples are 
representative of two independent collections. 
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Fig. 5. Expression of IGF-II/CI-MPR during Caco-2 differentiation. (A) 
Total RNA was isolated from Caco-2 cells on the indicated days in 
culture. RNA ( ~ 10/~g) was hybridized in solution to an IGF-II/CI-MPR 
probe and a RNase protection assay was performed as described under 
Section 2 (lanes 3-7). Yeast tRNA (10 /~g) was used as a negative 
control for any non-specific protection of the probe (lane 2). The size of 
the protected fragment (197 nts) is indicated as determined by migration 
with DNA sequencing ladders and corresponds to the expected full-length 
protection product. (B) The relative levels 4- S.E. of IGF-II/CI-MPR 
mRNA normalized to total RNA is shown during Caco-2 differentiation. 
The radiolabeled bands in A were normalized to the total RNA in the 
sample by quantifying the intensity of 28S rRNA stained with ethidium 
bromide in parallel gels using an Ambis-radioimaging system. IGF- 
I I /CI-MPR mRNA present in day 3 Caco-2 cells was arbitrarily set to 
100% (n = 6 from 3 independent RNA collections; P = 0.01 for day 12 
vs day 6, P = 0.18 for day 15 vs day 6). (C) Purified bovine liver 
IGF-II/CI-MPR (10-100 ng) and aliquots of IGF-II/CI-MPR isolated 
from two 100 mM dishes of Caco-2 cells at the indicated ays of culture 
(6.06, 8.94, 12.00, 15.46, and 13.98 mg of total cellular protein was used 
for day 3, 6, 9, 12, and 15 samples, respectively) were electrophoresed on 
a 7.5% polyacrylamide gel, transferred to lmmobilin-P membrane, and 
incubated with an IGF-II/CI-MPR-specific antisera plus [125I]protein A. 
The samples are representative of two independent collections. 
Y. Zhang et al. / Biochimica et Biophysica Acta 1267 (1995) 15-24 21 
and show that the levels of the CD-MPR mRNA increase 
(1.4-fold) during differentiation. To determine the steady- 
state levels of the CD-MPR protein during Caco-2 differ- 
entiation, quantitative We,;tern blot analysis was performed 
(Fig. 4C) and the results were normalized to total cellular 
protein• No significant differences in the steady-state levels 
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of the CD-MPR protein were observed between undiffer- 
entiated and differentiated Caco-2 cells and a mean value 
_ S.E. of 68.5 ___ 11.5 fmol CD-MPR was expressed in 
Caco-2 cells per milligram total protein (two independent 
collections, n = 4 for each sample day). 
3.5. Analysis of IGF-H / CI-MPR gene expression during 
Caco-2 differentiation 
Similar analyses as described above for the CD-MPR 
were performed to determine the expression levels of the 
IGF-II/CI-MPR gene during Caco-2 differentiation. The 
results show that the mRNA levels of the IGF-II/CI-MPR 
increase as differentiation progresses (Fig. 5A,B). As ob- 
served for the CD-MPR (Fig. 4), quantitative Western blot 
analysis (Fig. 5C) demonstrated no significant change in 
the steady-state l vels of the IGF-II/CI-MPR protein dur- 
ing Caco-2 differentiation and a mean value 4-S.E. of 
19.5 _+ 0.2 fmol IGF-II/CI-MPR was expressed in Caco-2 
cells per milligram total protein (two independent collec- 
tions, n = 4 for each sample day). A comparison of the 
levels of expression of the two MPRs showed that the 
CD-MPR is more abundant than the IGF-II/CI-MPR, with 
a molar ratio of the CD-MPR to the IGF-II/CI-MPR of 
3.5 to 1. Since several studies suggest hat the CD-MPR 
exists predominantly asa dimer in membranes [4], the ratio 
of functional CD-MPRs to IGF-II/CI-MPRs in Caco-2 
membranes would be 1.75 to 1. 
3.6. Expression of free and conjugated ubiquitin in differ- 
entiating Caco-2 cells 
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Fig. 6. Quantitation of the steady-state l vels of free and conjugated 
ubiquitin in Caco-2 cells. (A) The indicated cell samples (72 /xg each) 
that had been solubilized in SDS sample buffer were subjected to 
SDS-PAGE. The gel was then stained with Coomassie brilliant blue 
R-250 to detect otal cellular proteins. (B) Aliquots of the indicated cell 
samples (72 /zg each) used in panel A were subjected to Western analysis 
using a polyclonal antisera specific for free and conjugated ubiquitin. The 
migration of purified ubiquitin (2.5, 5, 10, or 20 ng) is shown. (C) 
Intensities of the radiolabeled bards shown in panel B were quantified on 
an Ambis-radioimaging system and the relative levels of free (O)  and 
conjugated (O)  ubiquitin are shown. The results are representative of
three independent experiments. 
To determine whether the cytoplasmic ubiquitin-depen- 
dent proteolytic pathway is regulated uring Caco-2 differ- 
entiation, the steady-state l vels of free ubiquitin and 
ubiquitin-protein conjugates were measured by Western 
blot analysis using a polyclonal antisera that recognizes 
both free and conjugated ubiquitin [32]. The Western blot 
(Fig. 6B) and a parallel gel stained with Coomassie blue 
(Fig. 6A) show that the pattern of ubiquitin-protein conju- 
gates, which range in size from ~ 24 to ~ 250 kDa, does 
not change significantly during Caco-2 differentiation. 
However, the level of both conjugated and free ubiquitin 
decreases 30% and 40%, respectively, during Caco-2 dif- 
ferentiation (Fig. 6C). 
4. Discussion 
To evaluate the roles of distinct degradative pathways 
in macromolecular turnover events of intestinal epithelial 
cells, the components of the lysosomal and ubiquitin-de- 
pendent degradative pathways were characterized in Caco-2 
cells during the process of spontaneous differentiation i
culture. After confluence, Caco-2 cells exhibit morphologi- 
cal and functional characteristics of intestinal absorbing 
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cells [14-18]. Our results showed that the activity of four 
lysosomal enzymes, a-o-mannosidase, /3-hexosaminidase, 
fl-glucuronidase, and fl-galactosidase, was 2- to 4-fold 
higher in differentiated, post-confluent Caco-2 cells than in 
actively dividing, pre-confluent Caco-2 cells. Increasing 
levels of the lysosomal enzymes cathepsin D and cathepsin 
B have also been observed uring Caco-2 differentiation 
[34]. Brush-border membrane proteins have been shown to 
exhibit a high tumover ate when compared to the other 
intestinal epithelial cellular proteins [35,36]. The involve- 
ment of lysosomal enzymes, such as cathepsin B, have 
been implicated in the turnover of brush-border hydrolases 
during postnatal development of the rat intestine [37]. In 
addition, recent studies by Matter et al. [38] demonstrated 
that two brush-border enzymes, sucrase-isomaltase and 
dipeptidylpeptidase IV, are delivered to the lysosome fol- 
lowing their recycling and endocytosis from the apical 
membrane. Taken together, these results indicate that the 
lysosomal degradative pathway plays a role in regulating 
the functional expression of at least several brush-border 
enzymes. Differentiated Caco-2 cells are also absorptive 
cells in which a portion of the proteins that are internalized 
undergo degradation [34]. Thus, the observed increase in 
lysosomal enzyme activity in differentiated Caco-2 cells 
may serve multiple roles in the turnover of both endoge- 
nous and exogenous macromolecules. 
Since the functional capacity of lysosomes in mediating 
protein turnover is dependent, in part, on MPR-dependent 
delivery of lysosomal enzymes to the lysosome, the ex- 
pression of the MPRs was analyzed uring the differentia- 
tion of Caco-2 cells. Metabolic labeling studies demon- 
strated that the IGF-II/CI-MPR and CD-MPR were syn- 
thesized by both proliferative and differentiated Caco-2 
cells (Fig. 2A). However, the apparent molecular weight of 
the CD-MPR was observed to decrease in post-confluent 
cells. Due to the limited resolution of high molecular 
weight proteins in SDS-polyacrylamide g ls, we were not 
able to determine whether the IGF-II/CI-MPR also exhib- 
ited changes in apparent molecular weight as a function of 
Caco-2 differentiation. Digestion of the CD-MPR with 
PNGase F resulted in the production of deglycosylated 
receptors with identical mobilities on SDS-polyacrylamide 
gels (Fig. 2B), demonstrating that the variation in size 
observed between the CD-MPR isolated from pre- and 
post-confluent cells was due to differences in the CD- 
MPRs' N-linked oligosaccharide structures. Changes in 
glycosylation, namely a decrease in the proportion of 
polylactosaminoglycans, have also been observed for the 
lysosomal membrane protein, lamp-l, during Caco-2 dif- 
ferentiation [39]. Taken together, these results suggest that 
the glycosylation machinery of Caco-2 cells is altered 
during the process of differentiation. Additional experi- 
ments will be required to determine the significance of 
altered oligosaccharide structures on the functional expres- 
sion of the CD-MPR in proliferative and differentiated 
intestinal epithelial cells. 
In contrast o the increased levels of lysosomal en- 
zymes, quantitative Western blot analyses demonstrated 
that the expression of either the IGF-II/CI-MPR (Fig. 5C) 
or CD-MPR (Fig. 4C) does not change during Caco-2 
differentiation. Since negligible amounts of lysosomal en- 
zyme activity were recovered from the culture medium, it 
is likely that the MPRs are expressed at sufficient amounts 
to efficiently deliver the elevated levels of lysosomal 
enzymes to the lysosome. Quantitation of the levels of 
expression of the MPRs revealed that the CD-MPR is 
expressed at a 3.5-fold molar excess over the IGF-II/CI- 
MPR. This result is consistent with the observation that, on 
a molar basis, the CD-MPR is more abundant (typically 
between 1.5- and 10-fold) than the IGF-II/CI-MPR in the 
majority of human tissues and human cell lines examined 
[40]. Since both the IGF-II/CI-MPR and CD-MPR can 
deliver lysosomal enzymes to the lysosome, it is not clear 
why both receptors are expressed simultaneously in most 
cell types [2-4]. However, subtle differences in the intra- 
cellular distribution of the two MPRs suggest differences 
in their function [41]. In addition, studies in which the 
IGF-II/CI-MPR or CD-MPR was overexpressed in a cell 
line deficient in the IGF-II/CI-MPR demonstrated that the 
IGF-II/CI-MPR is more efficient than the CD-MPR in 
delivering lysosomal enzymes to the lysosome [42,43]. 
Thus, the CD-MPR may be expressed at increased levels 
relative to the IGF-II/CI-MPR in order to compensate for 
its inefficiency in lysosomal enzyme targeting. 
The expression of the MPRs and their ligands has been 
analyzed during the myogenic differentiation of C2 my- 
oblasts [44,45]. In contrast o the results obtained in the 
current study, a coordinate increase in the levels of IGF- 
II/CI-MPR mRNA and protein as well as IGF-II mRNA, 
with no significant changes in the levels of the CD-MPR 
mRNA or several ysosomal enzyme activities, was ob- 
served to occur during the myogenic differentiation of C2 
cells [44,45]. These results suggest hat the IGF-II/CI- 
MPR's expression may be tightly correlated with the ex- 
pression of IGF-II, indicating a role for the receptor in 
growth factor signal transduction events. Studies are cur- 
rently under way to determine whether Caco-2 cells ex- 
press IGF-II and whether the expression of the IGF-II/CI- 
MPR and IGF-II are coordinately regulated uring Caco-2 
differentiation. 
Terminal differentiation of various cell types involves 
the reorganization of intracellular organelles and selective 
degradation of normally stable proteins. The ubiquitin 
system has been implicated to play important roles in this 
highly regulated proteolytic process since ubiquitin gene 
expression is rapidly down-regulated as human leukemia 
cells are induced to differentiate in culture [46], the occur- 
rence of extensive cytosolic ubiquitin-protein conjugates in
the lens of the chick embryo coincides temporally with 
differentiation events [47], and the levels of the ubiquitin 
conjugation enzymes, E2, decrease dramatically as rabbit 
reticulocytes mature into erythrocytes [32,48]. To deter- 
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mine whether the ubiquiti in-dependent proteolytic pathway 
may play an important role during Caco-2 differentiation, 
Western blot analyses were performed to measure the 
levels of free and conjugated ubiquitin. Our results indicate 
that ubiquitin and ubiquitin-protein conjugates are ex- 
pressed in Caco-2 cells, the steady-state l vels of which 
decrease ~ 40% and 30%, respectively, during Caco-2 
differentiation (Fig. 6). These results suggest that the 
remodeling of intracellul~x constituents that occurs during 
enterocyte differentiation may, in part, be carried out by 
the ubiquit in-dependent proteolytic pathway. However, ad- 
ditional experiments will l~e required to determine whether 
these ubiquitin-protein conjugates are, in fact, targeted for 
degradation or whether they exist as stable complexes that 
may play specific roles irk the proliferation and/or  differ- 
entiation of Caco-2 cells. 
In summary, we have demonstrated that the activities of 
several lysosomal enzyme.s increase while the steady-state 
levels of the CD-MPR and IGF- I I /C I -MPR remain un- 
changed during Caco-2 differentiation. In addition, we 
have shown that the ubiquit in-dependent proteolytic path- 
way is also regulated uring the process of Caco-2 differ- 
entiation. To our knowledge, these results represent he 
first report demonstrating; the presence of ubiquitin and 
ubiquitin-protein conjugates in intestinal epithelial cells. 
Future studies will be directed towards identifying those 
proteins targeted for degradation by the ubiquitin system, 
and more specifically, wh,ether ubiquitin is involved in the 
rapid tumover of hydrolases, transporters, and receptors of 
the brush-border membrane of intestinal epithelial cells. 
Acknowledgements 
This work was supported by NIH Grants DK44200 
(N.M.D.) and GM34009 (A.L.H.). 
References 
[1] Holtzman, E. (1989) Lysosomes, Plenum Press, New York. 
[2] von Figura, K. and Hasilik, A. (1986) Annu. Rev. Biochem. 55, 
167-193. 
[3] Nolan, C.M. and Sly, W.$. (1987) Adv. Exp. Med. Biol. 225, 
199-212. 
[4] Kornfeld, S. (1992) Annu. P, ev. Biochem. 61,307-330. 
[5] Tong, P.Y., ToUefsen, S.E. and Kornfeld, S. (1988) J. Biol. Chem. 
263, 2585-2588. 
[6] Waheed, A., Braulke, T., Janghans, U. and von Figura, K. (1988) 
Biochem. Biophys. Res. Commun. 152, 1248-1254. 
[7] Kiess, W., Blickenstaff, G.I)., Sklar, M.M., Thomas, C.L., Nissley, 
S.P. and Sahagian, G.G. (1988) J. Biol. Chem. 263, 9339-9344. 
[8] Ciechanover, A., Finley, E,. and Varshavsky, A. (1984) Cell 37, 
57-66. 
[9] Hershko, A., Eytan, E., Ciechanover, A. and Haas, A.L. (1982) J. 
Biol. Chem. 257, 13964-13970. 
[10] Finley, D. and Chan, V. (1991) Annu. Rev. Cell Biol. 7, 25-69. 
[11] Hershko, A. and Ciechanover, A. (1992) Annu. Rev. Biochem. 61, 
761-807. 
[12] Hough, R., Pratt, G. and Rechsteiner, M. (1987) J. Biol. Chem. 262, 
8303-8313. 
[13] Eastwood, G.L. (1977) Gastroenterology 72,962-975. 
[14] Pinto, M., Robine-Leon, S., Appay, M.-D., Kedinger, M., Triadou, 
N., Dussaulx, E., Lacroix, B., Simon-Assmann, P., Haffen, K., 
Fogh, J. and Zweibaum, A. (1983) Biol. Cell 47, 323-330. 
[15] Rousset, M. (1986) Biochimie 68, 1035-1040. 
[16] Blais, A., Bissonnette, P. and Berteloot, A. (1987) J. Membr. Biol. 
99, 113-125. 
[17] Hidalgo, LJ., Raub, T.J. and Borchardt, R.T. (1989) Gastroenterol- 
ogy 96, 736-749. 
[18] Ramanujam, K.S., Seetharam, S., Ramasamy, M. and Seetharam, B. 
(1991) Am. J. Physiol. 260, G416-G422. 
[19] Opheim, D.J. and Touster, O. (1978) Methods Enzymol. 50, 494- 
500. 
[20] Distler, J.J. and Jourdian, G.W. (1978) Methods Enzymol. 50, 
514-523. 
[21] Glaser, J.H. and Sly, W.S. (1973) J. Lab. Clin. Med. 82, 969-977. 
[22] Dahms, N.M., Rose, P.A., Molkentin, J.D., Zhang, Y. and Brzycki, 
M.A. (1993) J. Biol. Chem. 268, 5457-5463. 
[23] Laemmli, U.K. (1970) Nature 227, 680-685. 
[24] Dahms, N.M. and Hart, G.W. (1986) J. Biol. Chem. 261, 13186- 
13196. 
[25] Pohlmann, R., Nagel, G., Schmidt, B., Stein, M., Lorkowski, G., 
Krentler, C., Cully, J., Meyer, H.E., Grzeschik, K.-H., Mersmann, 
G., Hasilik, A. and von Figura, K. (1987) Proc. Natl. Acad. Sci. 
USA 84, 5575-5579. 
[26] Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, 
J.G., Smith, J.A. and Struhl, K. (1987) Current Protocols in Molecu- 
lar Biology (Current Protocols). 
[27] Chen, E.Y. and Seeburg, P.H. (1985) DNA 4, 165-170. 
[28] Morgan, D.O., Edman, J.C., Standring, D.N., Fried, V.A., Smith, 
M.C., Roth, R.A. and Rutter, W.J. (1987) Nature 329, 301-307. 
[29] MacDonald, R.J., Swift, G.H., Przybyla, A.E. and Chirgwin, J.M. 
(1987) Methods Enzymol. 152, 219-227. 
[30] Krieg, P.A. and Melton, D.A. (1987) Methods Enzymol. 155, 397- 
415. 
[31] Dahms, N. M, Wick, D.A. and Brzycki-Wessell, M.A. (1994) J. 
Biol. Chem. 269, 3802-3809. 
[32] Haas, A.L. and Bright, P.M. (1985) J. Biol. Chem. 260, 12464- 
12473. 
[33] Laburthe, M., Rousset, M., Rouyer-Fessard, C., Couvineau, A., 
Chantret, I., Chevalier, G. and Zweibaum, A. (1987) J. Biol. Chem. 
262, 10180-10184. 
[34] Heyman, M., Crain-Denoyelle, A.-M., Nath, S.K. and Desjeux, J.-F. 
(1990) J. Cell. Physiol. 143, 391-395. 
[35] James, W.P.T., Alpers, D.H., Gerber, J.E. and Isselbacher, K.J. 
(1971) Biochim. Biophys. Acta 230, 194-203. 
[36] Billington, T. and Nayadu, P.R.V. (1976) J. Membr. Biol. 27, 
83-100. 
[37] Seetharam, B., Yeh, K.Y. and Alpers, D.H. (1980) Am. J. Physiol. 
239, G524-G531. 
[38] Matter, K., Stieger, B., Klumperman, J. Ginsel, L. and Hauri, H.-P. 
(1990) J. Biol. Chem. 265, 3503-3512. 
[39] Youakim, A., Romero, P.A., Yee, K., Carlsson, S.R., Fukuda, M. 
and Herscovics, A. (1989) Cancer Res. 49, 6889-6895. 
[40] Wenk, J., Hille, A. and yon Figura, K. (1991) Biochem. Int. 23, 
723-731. 
[41] Klumperman, J. Hille, A., Veenendaal, T., Oorschot, V., Stoorvo- 
gel, W., von Figura, K. and Geuze, H.J. (1993) J. Cell Biol. 121, 
997-1010 
[42] Stein, M., Zijderhand-Bleekemolen, J.E., Geuze, H., Hasilik, A. and 
von Figura, K. (1987) EMBO J. 6, 2677-2681. 
24 Y. Zhang et al./ Biochimica et Biophysica Acta 1267 (1995) 15-24 
[43] Ma, Z.M., Grubb, J.H. and Sly, W.S. (1991) J. Biol. Chem. 266, 
10589-10595. 
[44] Tollefsen, S.E., Sadow, J.L. and Rotwein, P. (1989) Proc. Natl. 
Acad. Sci. USA 86, 1543-1547. 
[45] Szebenyi, G. and Rotwein, P. (1991) J. Biol. Chem. 266, 5534-5539. 
[46] Shimbara, N., Sato, C., Takashina, M., Tanaka, T., Tanaka, K. and 
Ichihara, A. (1993) FEBS Lett. 322, 235-239. 
[47] Scotting, P., McDermott, H., Lowe, J. and Mayer, R.J. (1991) FEBS 
Lett. 285, 75-79. 
[48] Pickart, C.M. and Vella, A.T. (1988) J. Biol. Chem. 263, 12028- 
12035. 
[49] Dahms, N.M., Lobel, P., Breitmeyer, J., Chirgwin, J.M. and Korn- 
feld, S. (1987) Cell 50, 181-192. 
